Organization appraisal system company vigorously strengthen safety risk prevention and control
Release time:
2022-03-22
News from our newspaper The prevention and control and evaluation of safety risks is an important part of the company's safety production management in the past two years. In order to further strengthen the safety risk prevention awareness of all employees and improve the safety management level, the company has carried out three consecutive years of safety risk prevention and control evaluation of the winning enterprises starting from 2022 , and at the same time formulated and issued the "Operation Safety Risk Assessment and Control System". It has been incorporated into the company's internal control management system.
safety risk prevention and control of the winning enterprise evaluation, is in the two phase safety and environmental protection accident-free factory created on the basis. From 2014 to 2016 , 2017 to 2021 , the company has successively carried out two phases of safety and environmental protection accident-free factory creation work in the whole group's production units, which has better promoted the standardization and standardization of safety and environmental protection management in the whole group. In order to further do a good job in safety production management and protect the lives and health of employees, the company decided to carry out safety risk prevention and control evaluation activities based on the experience of creating an "accident-free factory. The enterprises included in the appraisal are the production department of the group's subordinate enterprises and pharmaceutical companies, Anhui Xinbeika Chemical, Jianfeng Beika Pharmaceutical and other pharmaceutical plate manufacturers. The selection is led by the safety management office of the group company, and will be evaluated once a year at the end of the year starting from 2022 , with a tentative period of three years. According to the annual safety management results of each participating unit and the on-site safety supervision of the group company, the annual scores of each enterprise are calculated by combining qualitative and quantitative methods, and are ranked from high to low. After being approved by the company's safety committee, the top three enterprises that meet the conditions will be rewarded.
activity scoring rules are divided into qualitative and quantitative parts, of which the qualitative part is the necessary condition for winning the award, including the establishment of safety risk prevention and control mechanism and normal implementation, the comprehensive signing of safety production responsibility system, and no fire and explosion accidents with direct economic losses of more than 10 yuan, no direct economic loss of more than 10 yuan or more than 9 (inclusive) work-related accidents, no concealment of safety accidents, annual evaluation score of 70 or more, any failure to do so, are not allowed to participate in the evaluation of enterprises with superior safety risk prevention and control; The quantitative part includes the implementation of safety inspection, training, activities, etc.
Company requires that all units formulate implementation rules in combination with the actual situation of the enterprise, earnestly do a good job in public opinion publicity and safety risk prevention and control training, publicize the importance of safety risk prevention and control work and the harmfulness of accidents to employees, guide employees to consciously implement safety risk prevention and control measures, and improve the ability of safety risk prevention and control; Consolidate the previous achievements of employees' work safety education, and put 50 articles on "Typical Violations, as a normalized safety education content, employees are required to master and use it proficiently to avoid illegal operations; improve and refine safety risk prevention and control measures, strengthen the inspection and assessment of the implementation process, and strive for the continuous, stable and good development of the safety management situation.
The "Operation Safety Risk Assessment and Control System" recently introduced the management goal of standardizing operation safety procedures, effectively controlling the safety risks of various operations, and achieving "zero injury. The types and scope of operations included in safety risk control include equipment repair, technical renovation and installation works, temporary object handling and unloading, equipment blocking, warehouse cleaning, civil construction, trial production of new equipment, new products, new processes and new materials, pilot test of product development, etc., and other types of operations other than daily productive routine operations. These operation items shall be subject to safety risk assessment first, risk level shall be determined, preventive measures shall be formulated, operation safety risk control form shall be filled in and approved before operation. According to the degree of operational risk and possible consequences, the system also makes detailed provisions on the classification of risk assessment, the formulation principles of operational safety risk prevention measures, the filling and approval of operational safety risk control forms, and operational safety monitoring regulations.
As an important part of the internal management of the enterprise, the Operation Safety Risk Assessment and Control System has been incorporated into the internal control management system of CNPC and will be continuously revised and improved in future work. (this newspaper reporter)
More information
2020
11-03
Jinhua Municipal Party Committee Secretary Chen Long: I wish your enterprise better and better
On the morning of October 16, Chen long, secretary of the Jinhua Municipal CPC Committee, and his entourage came to the construction site of Jianfeng Pharmaceutical's internationalization project to investigate and affirmed the good development status and clear future development ideas of Jianfeng Pharmaceutical. At the construction site, Jiang Xiaomeng, chairman of the group company and chairman of the pharmaceutical company, introduced the overall situation of the investment scale, factory layout, and production direction of the Jianfeng Pharmaceutical internationalization project to Chen Long and his entourage. Huang Jinlong, general manager of the pharmaceutical company, accompanied Chen Long and his entourage to visit the preparation workshop under construction. The construction site is neat, tidy and orderly, and the facilities and equipment are perfect and advanced, all have been unanimously affirmed by the leaders who came to investigate. When learning that the peak internationalization project has introduced international advanced equipment, built in accordance with European and American standards, and its products are oriented to the international market, Chen long said happily: "your goals are very clear and your thinking is very clear. I wish your enterprise better and better!" (this newspaper reporter)
2020
10-23
Liu Haiping, vice mayor of Pu'er City, said during the survey: "Peak is an enterprise with feelings"
On September 30, Liu Haiping, member of the standing Committee of the Pu'er Municipal CPC Committee and vice mayor of Pu'er City, Yunnan Province, and relevant responsible persons of Pu'er City and Simao District, visited the company for investigation and research, and communicated with the leaders of the group company on topics such as further strengthening cooperation between the two sides. "Yunnan Jianfeng has not only developed well in Pu'er these years, achieved good benefits and contributed considerable tax revenue, but also made great contributions to promoting the economic development of Pu'er and the stability of the southwest border region. It is our 'star enterprise' and 'baby enterprise '." Liu Haiping said so in the exchange. He said that Pu'er is an important window for the implementation of the "Belt and Road" concept. It has good conditions in natural resources, transportation, electricity, etc., and the peak is a "sentimental enterprise" and has a good foundation in the local area. Strengthen cooperation; various government departments will also earnestly "stand on the platform" and "do a good job as a shopkeeper" to serve enterprises. Chairman Jiang Xiaomeng and General Manager Yu Jianhong exchanged views with Liu Haiping and his party on the layout of peak industry and strengthening cooperation with Pu 'er. After that, accompanied by General Manager Yu Jianhong and Deputy General Manager Huang Jinlong, Liu Haiping and his party visited the Jinxi Factory of Jianfeng Pharmaceutical Factory. (this newspaper reporter)
2020
10-09
The first batch of Jianfeng Pharmaceuticals to enter Jinhua (Shanghai) Science and Technology Center
News from our newspaper On September 16, at the unveiling ceremony of the Yangtze River Delta G60 Jinhua (Shanghai) Science and Technology Innovation Center and Jinhua (Shanghai) Talent Building, Jiang Xiaomeng, chairman of the group company and chairman of the pharmaceutical company, took over from Chen Long, secretary of the Jinhua Municipal Party Committee. The golden key with big red flowers. Spike Pharmaceuticals became one of the first seven companies to enter the center. The Yangtze River Delta G60 Jinhua (Shanghai) Science and Technology Center and Jinhua (Shanghai) Talent Building are the first "Science and Technology and Talent Enclave" in Shanghai in the nine cities of the Yangtze River Delta G60 Science and Technology Corridor, and the first cross-regional industrial collaborative innovation center in the Science and Technology Corridor. The center is located in Shanghai Lingang Songjiang Science and Technology City, with a total area of nearly 10,000 square meters. It includes two parts: science and technology innovation and talent service. There are five major centers, including talent service center, science and technology innovation exhibition center, business incubation center, enterprise research and development center, and talent project roadshow center. It is a science and technology innovation platform that integrates the functions of project incubation, recruitment of institutions, and talent recruitment. Chen Long, secretary of the Jinhua Municipal Party Committee, said in his speech at the unveiling ceremony that in the future, all scientific and technological enterprises stationed in Jinhua (Shanghai) Science and Technology Center and Talent Building can equally enjoy Jinhua's local science and technology and talent policies, so as to further break the space limitation, enable talents from the two places to share the most favorable treatment and convenient services, help enterprises to develop in Shanghai and achieve industrialization in Jinhua. At the ceremony, leaders such as Chen Long, secretary of the Jinhua Municipal Party Committee, and Cheng Xiangmin, secretary of the Shanghai Songjiang District Party Committee, awarded seven companies, including Jianfeng Pharmaceutical, the golden key to symbolize their entry. At the Yangtze River Delta Integrated Talent Cooperation Project Symposium held after the ceremony, Jiang Xiaomeng spoke as a representative of Jinhua entrepreneurs. He believed that Shanghai, as an international metropolis, has an agglomeration effect on high-end intellectual resources and grasps the first-class element resources of scientific and technological innovation in China and even the world. The establishment of G60 Jinhua (Shanghai) science and technology innovation center and talent building in the Yangtze River Delta helps Jinhua enterprises to take off in scientific and technological innovation and information exchange, which will provide strong and continuous scientific and technological support and intellectual support for the long-term development of enterprises in the future, and attract more excellent domestic and foreign talents to serve Jinhua enterprises, It plays a key role in further improving scientific research ability, innovation ability and personnel training. During the event, Jiang Xiaomeng successively accepted on-site interviews with "People's Daily", "Liberation Daily", "Zhejiang Daily" and other media. He said that the establishment of science and technology innovation and talent bases in Shanghai has greatly enhanced Jinhua's attractiveness to enterprises. "With this base, we don't need to introduce talents to Jinhua, but directly recruit talents in Shanghai, and at the same time enjoy Jinhua's various talent recruitment policies, and change Shanghai talents to Jinhua's use. This is a kind of bold. The innovation has greatly solved the dilemma of attracting talents for enterprises." As a settled enterprise, it will also make full use of its own advantages to continuously inject resource vitality into the science and technology innovation center, and continue to contribute to the long-term development of Jinhua's economy. (this newspaper reporter)
2020
09-22
Spike Pharmaceutical Added New Products
On September 3, Spike Pharmaceutical Company received the approval of the State Drug Administration for the registration of esomeprazole sodium for injection (approval number: 2020S00572). Esomeprazole sodium for injection is mainly used to treat low-risk patients with gastroesophageal reflux disease and acute gastric or duodenal ulcer bleeding when oral therapy is not applicable. It has been listed in the National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug List (2017 Edition) ", classified as Class B. According to industry statistics, 30 companies including Zhengda Tianqing and Qilu Pharmaceutical have been approved for listing in China. In 2019, domestic sales (including urban and county-level public hospitals, community and township health centers) were about 3.317 billion yuan. Jianfeng Pharmaceutical submitted an application for registration of esomeprazole sodium for injection to the State Food and Drug Administration in November 2013 and was accepted. Up to now, Jianfeng Pharmaceutical has invested nearly 15 million yuan in research and development for the project and has a corresponding production line. This time to obtain the injection of esomeprazole sodium drug registration approval, marking the peak pharmaceutical has the drug production, sales qualification, will further enrich the peak pharmaceutical product line, help to enhance the competitiveness of the peak pharmaceutical business. (Lu Yating, Liu Yang)
2020
09-11
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page